JESSICA LAWRENCE: Open Payments
NPI 1609100536 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,764 in 122 payments from 27 companies in 2025. Trend: 2023 $3,104 · 2024 $2,344 · 2025 $2,764
Food & beverage: $2,674Education: $90
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $446 |
| Janssen Biotech, Inc. | 15 | $421 |
| Dendreon Pharmaceuticals LLC | 14 | $418 |
| PFIZER INC. | 8 | $160 |
| COLOPLAST CORP | 9 | $153 |
| Antares Pharma, Inc. | 6 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| Merck Sharp & Dohme LLC | 6 | $130 |
| Boston Scientific Corporation | 5 | $123 |
| TOLMAR, INC. | 5 | $90 |
Products named: ERLEADA, PROVENGE, ORGOVYX, XTANDI, GEMTESA, XYOSTED, PLUVICTO, Titan.
Industry payments across TN — which companies pay providers there.
